Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Project Name | Project Stage | Molecule Type | Host Species | Therapeutic Area | Indications |
CLDN6 mAb - 01 | PCC | Solid Tumor | Ovarian cancer,Lung adenocarcinoma |
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CHEK-ATP138 | Human | HEK293/Human Claudin-6 Stable Cell Line | |||
CL6-H52P7 | Human | Human Claudin-6 / CLDN6 Full Length Protein (VLP) |
|
||
CL6-HF2G8 | Human | Fluorescent Human Claudin-6 / CLDN6 Full Length Protein (VLP) |
|
||
CL6-HF2M9 | Human | Fluorescent Human Claudin-6 / CLDN6 Protein, Flag,His,GFP Tag (Nanodisc) |
|
|
|
CL6-H5286 | Human | Human Claudin-6 / CLDN6 Protein, His,Twin-Strep Tag (Nanodisc) |
|
|
|
CL6-H5289 | Human | Human Claudin-6 / CLDN6 Protein, His,Twin-Strep Tag (Detergent) |
|
|
2e5 of anti-Claudin-6 CAR-293 cells were stained with 100 μL of 1 μg/mL of Fluorescent Human Claudin-6 Protein, Flag,His,GFP Tag (Cat. No.CL6-HF2M9) and negative control protein respectively (Fig. A and B), FITC signal was used to evaluate the binding activity (QC tested).
Human Claudin-6 Full Length Protein (VLP) (Cat. No. CL6-H52P7) captured on L1 Chip can bind Anti-Claudin-6 Antibody, Human IgG1 with an affinity constant of 57.8 pM as determined in a SPR assay (Biacore 8K) (Routinely tested).
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
SC-004 | SC-004 | Taisho Pharmaceutical Holdings Co Ltd | Details | ||
CLDN6 CAR-T cell therapy (BioNTech) | BNT-211 | Biontech Se | Details | ||
CLDN6-CAR-NK Cell Therapy | Phase 2 Clinical | Second Affiliated Hospital Of Guangzhou Medical University | Ovarian Neoplasms; Testicular Neoplasms; Endometrial Neoplasms | Details | |
DS-9606a | DS-9606a; DS-9606-a | Phase 1 Clinical | Daiichi Sankyo Inc | Ovarian Neoplasms; Neoplasms; Neoplasm Metastasis; Neoplasms, Germ Cell and Embryonal | Details |
AMG-794 | AMG-794 | Phase 1 Clinical | Amgen Inc | Carcinoma, Ovarian Epithelial; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.